p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis

Cancer Cell

Volumn 11, Issue 2, 2007, Pages 191-205

  Dolado, Ignacio ^a,b   Swat, Aneta ^a   Ajenjo, Nuria ^a   De Vita, Gabriella ^c   Cuadrado, Ana ^a   Nebreda, Angel R ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE 14; PROTEIN H RAS; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M2 2; GLUTATHIONE TRANSFERASE M2-2; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL STRAIN MCF 7; EMBRYO; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL TRANSFORMATION; CYTOLOGY; ENZYME ACTIVATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; NEOPLASM; ONCOGENE RAS; PATHOLOGY; PHYSIOLOGY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; GENES, RAS; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 14; MITOGEN-ACTIVATED PROTEIN KINASE 3; MOLECULAR SEQUENCE DATA; NADPH OXIDASE; NEOPLASMS; OXIDATIVE STRESS; RAC1 GTP-BINDING PROTEIN; REACTIVE OXYGEN SPECIES; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION;

EID: 33846811520     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.12.013     Document Type: Article

References (57)

1. Allen R.G., and Tresini M. Oxidative stress and gene regulation. Free Radic. Biol. Med. 28 (2000) 463-499
2. Alonso G., Ambrosino C., Jones M., and Nebreda A.R. Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength. J. Biol. Chem. 275 (2000) 40641-40648
3. Ambrosino C., Mace G., Galban S., Fritsch C., Vintersten K., Black E., Gorospe M., and Nebreda A.R. Negative feedback regulation of MKK6 mRNA stability by p38α mitogen-activated protein kinase. Mol. Cell. Biol. 23 (2003) 370-381
4. Ames B.N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221 (1983) 1256-1264
5. Bos J.L. ras oncogenes in human cancer: a review. Cancer Res. 49 (1989) 4682-4689
6. Brancho D., Tanaka N., Jaeschke A., Ventura J.J., Kelkar N., Tanaka Y., Kyuuma M., Takeshita T., Flavell R.A., and Davis R.J. Mechanism of p38 MAP kinase activation in vivo. Genes Dev. 17 (2003) 1969-1978
7. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 31 (2002) 210-215
8. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., and Fornace Jr. A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 36 (2004) 343-350
9. Chen G., Hitomi M., Han J., and Stacey D.W. The p38 pathway provides negative feedback for Ras proliferative signaling. J. Biol. Chem. 275 (2000) 38973-38980
10. Cho S.G., Lee Y.H., Park H.S., Ryoo K., Kang K.W., Park J., Eom S.J., Kim M.J., Chang T.S., Choi S.Y., et al. Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J. Biol. Chem. 276 (2001) 12749-12755
11. Church S.L., Grant J.W., Ridnour L.A., Oberley L.W., Swanson P.E., Meltzer P.S., and Trent J.M. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. USA 90 (1993) 3113-3117
12. Cowley S., Paterson H., Kemp P., and Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77 (1994) 841-852
13. De Vita G., Bauer L., da Costa V.M., De Felice M., Baratta M.G., De Menna M., and Di Lauro R. Dose-dependent inhibition of thyroid differentiation by RAS oncogenes. Mol. Endocrinol. 19 (2005) 76-89
14. Dorion S., Lambert H., and Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J. Biol. Chem. 277 (2002) 30792-30797
15. Downward J. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003) 11-22
16. Elenitoba-Johnson K.S., Jenson S.D., Abbott R.T., Palais R.A., Bohling S.D., Lin Z., Tripp S., Shami P.J., Wang L.Y., Coupland R.W., et al. Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy. Proc. Natl. Acad. Sci. USA 100 (2003) 7259-7264
17. Emerling B.M., Platanias L.C., Black E., Nebreda A.R., Davis R.J., and Chandel N.S. Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol. Cell. Biol. 25 (2005) 4853-4862
18. Evan G.I., and Vousden K.H. Proliferation, cell cycle, and apoptosis in cancer. Nature 411 (2001) 342-348
19. Faust D., Dolado I., Cuadrado A., Oesch F., Weiss C., Nebreda A.R., and Dietrich C. p38α MAPK is required for contact inhibition. Oncogene 24 (2005) 7941-7945
20. Fernandez-Pol J.A., Hamilton P.D., and Klos D.J. Correlation between the loss of the transformed phenotype and an increase in superoxide dismutase activity in a revertant subclone of sarcoma virus-infected mammalian cells. Cancer Res. 42 (1982) 609-617
21. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
22. Hancock J.T., Desikan R., and Neill S.J. Role of reactive oxygen species in cell signalling pathways. Biochem. Soc. Trans. 29 (2001) 345-350
23. Irani K., Xia Y., Zweier J.L., Sollott S.J., Der C.J., Fearon E.R., Sundaresan M., Finkel T., and Goldschmidt-Clermont P.J. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275 (1997) 1649-1652
24. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., and Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12 (2006) 446-451
25. Kamata H., and Hirata H. Redox regulation of cellular signalling. Cell. Signal. 11 (1999) 1-14
26. Kennedy N.J., and Davis R.J. Role of JNK in tumor development. Cell Cycle 2 (2003) 199-201
27. Kim M.S., Lee E.J., Kim H.R., and Moon A. p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res. 63 (2003) 5454-5461
28. Kurata S. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J. Biol. Chem. 275 (2000) 23413-23416
29. Lavoie J.N., L'Allemain G., Brunet A., Muller R., and Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271 (1996) 20608-20616
30. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., and Finkel T. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274 (1999) 7936-7940
31. Li S.P., Junttila M.R., Han J., Kahari V.M., and Westermarck J. p38 mitogen-activated protein kinase pathway suppresses cell survival by inducing dephosphorylation of mitogen-activated protein/extracellular signal-regulated kinase kinase1,2. Cancer Res. 63 (2003) 3473-3477
32. Maciag A., and Anderson L.M. Reactive oxygen species and lung tumorigenesis by mutant K-ras: a working hypothesis. Exp. Lung Res. 31 (2005) 83-104
33. Mansour S.J., Matten W.T., Hermann A.S., Candia J.M., Rong S., Fukasawa K., Vande Woude G.F., and Ahn N.G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265 (1994) 966-970
34. Matsukawa J., Matsuzawa A., Takeda K., and Ichijo H. The ASK1-MAP kinase cascades in mammalian stress response. J. Biochem. 136 (2004) 261-265
35. Mitsushita J., Lambeth J.D., and Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res. 64 (2004) 3580-3585
36. Nakayama K., Gazdoiu S., Abraham R., Pan Z.Q., and Ronai Z. Hypoxia-induced assembly of prolyl-hydroxylase, PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Biochem. J. 401 (2007) 217-226
37. Nebreda A.R., and Porras A. p38 MAP kinases: beyond the stress response. Trends Biochem. Sci. 25 (2000) 257-260
38. Nicke B., Bastien J., Khanna S.J., Warne P.H., Cowling V., Cook S.J., Peters G., Delpuech O., Schulze A., Berns K., et al. Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth arrest in human ovarian surface epithelial cells. Mol. Cell 20 (2005) 673-685
39. Parl F.F. Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 221 (2005) 123-129
40. Porras A., Zuluaga S., Black E., Valladares A., Alvarez A.M., Ambrosino C., Benito M., and Nebreda A.R. P38 α mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol. Biol. Cell 15 (2004) 922-933
41. Qi X., Tang J., Pramanik R., Schultz R.M., Shirasawa S., Sasazuki T., Han J., and Chen G. p38 MAPK activation selectively induces cell death in K-ras-mutated human colon cancer cells through regulation of vitamin D receptor. J. Biol. Chem. 279 (2004) 22138-22144
42. Santillo M., Mondola P., Seru R., Annella T., Cassano S., Ciullo I., Tecce M.F., Iacomino G., Damiano S., Cuda G., et al. Opposing functions of Ki- and Ha-Ras genes in the regulation of redox signals. Curr. Biol. 11 (2001) 614-619
43. Sattler M., Winkler T., Verma S., Byrne C.H., Shrikhande G., Salgia R., and Griffin J.D. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood 93 (1999) 2928-2935
44. Sattler M., Verma S., Shrikhande G., Byrne C.H., Pride Y.B., Winkler T., Greenfield E.A., Salgia R., and Griffin J.D. The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells. J. Biol. Chem. 275 (2000) 24273-24278
45. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., and Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401 (1999) 79-82
46. Szatrowski T.P., and Nathan C.F. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51 (1991) 794-798
47. Tobiume K., Matsuzawa A., Takahashi T., Nishitoh H., Morita K., Takeda K., Minowa O., Miyazono K., Noda T., and Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2 (2001) 222-228
48. Townsend D.M., and Tew K.D. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22 (2003) 7369-7375
49. Toyokuni S. Novel aspects of oxidative stress-associated carcinogenesis. Antioxid. Redox Signal. 8 (2006) 1373-1377
50. Toyokuni S., Okamoto K., Yodoi J., and Hiai H. Persistent oxidative stress in cancer. FEBS Lett. 358 (1995) 1-3
51. Wada T., and Penninger J.M. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 23 (2004) 2838-2849
52. Wang W., Chen J.X., Liao R., Deng Q., Zhou J.J., Huang S., and Sun P. Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol. Cell. Biol. 22 (2002) 3389-3403
53. Weijzen S., Rizzo P., Braid M., Vaishnav R., Jonkheer S.M., Zlobin A., Osborne B.A., Gottipati S., Aster J.C., Hahn W.C., et al. Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells. Nat. Med. 8 (2002) 979-986
54. Wolfman J.C., Palmby T., Der C.J., and Wolfman A. Cellular N-Ras promotes cell survival by downregulation of Jun N-terminal protein kinase and p38. Mol. Cell. Biol. 22 (2002) 1589-1606
55. Woo R.A., and Poon R.Y. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev. 18 (2004) 1317-1330
56. Xia Y., Makris C., Su B., Li E., Yang J., Nemerow G.R., and Karin M. MEK kinase 1 is critically required for c-jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration. Proc. Natl. Acad. Sci. USA 97 (2000) 5243-5248
57. Yujiri T., Sather S., Fanger G.R., and Johnson G.L. Role of MEKK1 in cell survival and activation of JNK and ERK pathways defined by targeted gene disruption. Science 282 (2000) 1911-1914